Myocardial Fibrosis Caused by Angiotensin II Implant in Rabbit Atherosclerosis Model Induced by High Cholesterol Diet

Rabbits are widely used in biomedical research as models for atherosclerosis with disease induction achieved through a high-cholesterol diet, transgenic approaches, or spontaneous development with aging. At our institution, New Zealand White rabbits were induced to develop atherosclerosis via a high-cholesterol diet followed by arterial balloon injury. This model was established to support intravascular molecular imaging studies aimed at tracking atheromatous plaque progression in vivo. To accelerate plaque development, a subcutaneous osmotic pump delivering angiotensin II at 50 ng/kg/min was implanted. While this method enhanced disease progression, unexpected clinical complications were observed. In this retrospective case report, we reviewed clinical records from 54 rabbits over a 2-year period. Clinically, most study animals showed different levels of inappetence. Three presented respiratory symptoms including cyanosis, dyspnea, or tachypnea, while another 3 exhibited neurologic signs such as altered mentation and paralysis. Eight rabbits (14.8%) were euthanized due to severe clinical signs. Necropsy findings in the affected animals commonly revealed pleural and/or peritoneal effusion; one case included chyloabdomen, a condition not previously reported in rabbits. Of these, 7 had myocardial degeneration and fibrosis. These findings suggest that angiotensin II infusion in this rabbit model of atherosclerosis may induce myocardial fibrosis as a significant adverse effect. This report highlights potential complications associated with the model and provides guidance for clinical monitoring, diagnosis, and management in future studies.